Search

Ofev®

Ofev® is a prescription medication used to treat people with idiopathic pulmonary fibrosis (IPF) systemic sclerosis-associated interstitial lung disease (SSc-ILD) and other chronic fibrosing interstitial lung diseases with a progressive phenotype

Heart Diseases

Major investment for respiratory diseases completed

105 million euros invested into expansion of production facilities in Ingelheim and Dortmund

Transboundary animal diseases and veterinary preparedness

What are transboundary animal diseases (TADs)? Bluetongue virus, foot-and-mouth disease and avian influenza are pathogens belonging to this group.

What do you know about transboundary animal diseases

Transboundary animal diseases (TADs) are highly transmissible diseases of livestock that can impact veterinary public health preparedness.

Stargardt Disease

Stargardt Disease is a hereditary condition which causes degeneration of cells in the retina at the back of the eye.

Quick response in fighting Foot-and-Mouth-Disease

Helping to contain an outbreak of the disease on the island of Rodrigues in just six days.

Boehringer and ZEISS partnership eye diseases

Boehringer Ingelheim and ZEISS join forces to early detect eye diseases and prevent vision loss

Partnering with Lifebit to detect global disease outbreaks

Boehringer Ingelheim partners with Lifebit to detect global infectious disease outbreaks

FDA approves Jardiance treatment chronic kidney disease

U.S. FDA approves Jardiance® for treatment of adults with chronic kidney disease

Chronic kidney disease in cats

Detect and manage chronic kidney disease and high blood pressure in cats

Skin Diseases

Metabolic Diseases

Rare Diseases: Rare but not alone

We are committed to listen and learn from patients with rare diseases to deliver breakthrough therapies.

Bluetongue disease

The bluetongue virus is a viral disease that affects ruminants' health. It doesn't affect humans, but it is a threat to animals.

Full data chronic kidney disease trial efficacy

Positive full data results announced from the EMPA-KIDNEY Phase III trial in adults with chronic kidney disease

PREVEXXION® RN: Marek’s disease vaccine available in EU UK

Boehringer Ingelheim is pleased to announce the launch of the next generation of Marek’s disease vaccines is now available in the EU.

Central Nervous System Diseases

Find out more about our research and development in central nervous system diseases

Chronic kidney disease is a silent killer

Living with chronic kidney disease can have drastic impacts on a patient and their family’s life. A patient and her caregiver share their story on managing it.

FDA accepts new chronic kidney disease treatment application

New vaccine against Bovine Respiratory Disease

Boehringer Ingelheim’s Bovalto Respi Intranasal is a new respiratory vaccine for active immunization of cattle against Bovine Respiratory Disease.

Do you take periodontal disease in dogs seriously? We do!

Periodontal Disease? Brushing teeth is vital to prevent doggy breath, but not enough to ensure animal health and well-being

Partnership for new liver disease treatments with Ribo

Boehringer Ingelheim partners with Ribo to develop new treatments for people with liver diseases

Generalized pustular psoriasis (GPP): a rare, chronic, systemic disease

A rare, chronic, systemic autoinflammatory disease that can be life-threatening if left untreated.

Cardiometabolic Diseases

We are looking for new early-science collaborations and invite you to join our expanding community of innovation partners in CardioMetabolic diseases.

About Us

Human Health

Animal Health

Science & Innovation

Partnering

Careers